Skip to main content

Jim Cramer: Sarepta Could Be a Takeover Target, but I'm Not Buying Shares

Shares of drug-maker Sarepta are higher Tuesday on the back of an upgrade from RBC, but Jim Cramer says he's not adding shares to his portfolio.
  • Author:
  • Publish date:

Shares of drugmaker Sarepta (SRPT) - Get Sarepta Therapeutics, Inc. Report are higher Tuesday on the back of an upgrade from RBC, but Jim Cramer says he's not adding shares to his portfolio. Cramer says that while it's possible that the company could get a takeover offer, he believes the easy money has been made. "I don't like to come in on top of the easy money being made," says Cramer. Sarepta shares have more than doubled over the past month, following a challenging start to 2016.  

TheStreet Recommends